Biosimilar Herzuma launching in Europe for the treatment of breast cancer

10:02 EDT 3 May 2018 | thePharmaLetter

The Mundipharma global network of independent associated companies today announced that Herzuma, biosimilar

More From BioPortfolio on "Biosimilar Herzuma launching in Europe for the treatment of breast cancer"